These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34668223)

  • 1. Fracture Risk Following an Atypical Femoral Fracture.
    Bégin MJ; Audet MC; Chevalley T; Portela M; Padlina I; Hannouche D; Ing Lorenzini K; Meier R; Peter R; Uebelhart B; Rizzoli R; Ferrari S; Biver E
    J Bone Miner Res; 2022 Jan; 37(1):87-94. PubMed ID: 34668223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates and the risk of atypical femur fractures.
    Black DM; Condra K; Adams AL; Eastell R
    Bone; 2022 Mar; 156():116297. PubMed ID: 34920168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis.
    Wong CH; Kan AKC; Tsoi KH; Chan SSY; Jiang NS; Loong CHN; Fong CHY; Wong JSH; Shea GKH; Cheung CL; Lee CH; Tan KCB; Woo YC; Lui DTW
    Endocrine; 2024 Apr; 84(1):223-235. PubMed ID: 37985574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the incidence of atypical femoral fractures and bisphosphonate therapy.
    Clout A; Narayanasamy N; Harris I
    J Orthop Surg (Hong Kong); 2016 Apr; 24(1):36-40. PubMed ID: 27122510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.
    Eisenstein N; Kasavkar G; Bhavsar D; Khan FS; Paskins Z
    BMC Musculoskelet Disord; 2017 Jan; 18(1):29. PubMed ID: 28114975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of bisphosphonate and non-bisphosphonate related atypical femoral fracture in a South East Asian population - Secondary analysis.
    Gani LU; Anthony NF; Dacay LM; Tan PT; Chong LR; King TFJ
    Bone; 2022 Sep; 162():116455. PubMed ID: 35688361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review.
    Bauer DC; Black DM; Dell R; Fan B; Smith CD; Ernst MT; Jurik AG; Frøkjær JB; Boesen M; Vittinghoff E; Abrahamsen B
    J Clin Endocrinol Metab; 2024 Oct; 109(11):e2141-e2150. PubMed ID: 38198798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years.
    Lo JC; Neugebauer RS; Ettinger B; Chandra M; Hui RL; Ott SM; Grimsrud CD; Izano MA
    BMC Musculoskelet Disord; 2020 Dec; 21(1):801. PubMed ID: 33272248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate treatment and the risk of atypical femoral fracture among patients participating in a Fracture Liaison Service of a tertiary medical center.
    Bareli N; Gat R; Makarov V; Siris E; Fraenkel M; Yoel U
    Arch Osteoporos; 2021 Jun; 16(1):86. PubMed ID: 34089098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.
    Zhang HY; Weng HL; Li M; Zhang J
    Osteoporos Int; 2019 Nov; 30(11):2349-2354. PubMed ID: 31428823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.
    van de Laarschot DM; McKenna MJ; Abrahamsen B; Langdahl B; Cohen-Solal M; Guañabens N; Eastell R; Ralston SH; Zillikens MC
    J Clin Endocrinol Metab; 2020 May; 105(5):1682-99. PubMed ID: 31867670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
    Lim SJ; Yeo I; Yoon PW; Yoo JJ; Rhyu KH; Han SB; Lee WS; Song JH; Min BW; Park YS
    Osteoporos Int; 2018 Nov; 29(11):2427-2435. PubMed ID: 30039251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiological criteria for atypical features of femur fractures: what we can learn when applied in a clinical study setting.
    LeBlanc ES; Rosales AG; Genant HK; Dell RM; Friess DM; Boardman DL; Santora AC; Bauer DC; de Papp AE; Black DM; Orwoll ES
    Osteoporos Int; 2019 Jun; 30(6):1287-1295. PubMed ID: 30809724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Femoral Fracture in Rheumatoid Arthritis Patients Treated With Bisphosphonates: A Nested Case-Control Study.
    Koh JH; Myong JP; Jung SM; Lee J; Kwok SK; Park SH; Ju JH
    Arthritis Rheumatol; 2016 Jan; 68(1):77-82. PubMed ID: 26360133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential bone fragility of mid-shaft atypical femoral fracture: Biomechanical analysis by a CT-based nonlinear finite element method.
    Tano A; Oh Y; Fukushima K; Kurosa Y; Wakabayashi Y; Fujita K; Yoshii T; Okawa A
    Injury; 2019 Nov; 50(11):1876-1882. PubMed ID: 31519437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
    Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y
    J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate therapy associated with bilateral atypical femoral fracture and delayed union.
    Gárgyán I; Dózsai D; Csonka I; Rárosi F; Bodzay T; Csonka Á
    Jt Dis Relat Surg; 2022; 33(1):24-32. PubMed ID: 35361077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MANAGEMENT OF ENDOCRINE DISEASE: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy.
    Adler RA
    Eur J Endocrinol; 2018 Mar; 178(3):R81-R87. PubMed ID: 29339529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy.
    Qiu S; Dhaliwal R; Divine G; Warner E; Rao SD
    J Bone Miner Res; 2024 May; 39(4):417-424. PubMed ID: 38477744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.
    Tsuchie H; Miyakoshi N; Iba K; Kasukawa Y; Nozaka K; Dohke T; Kosukegawa I; Aizawa T; Maekawa S; Abe H; Takeshima M; Tomite T; Segawa T; Ouchi K; Kinoshita H; Suzuki M; Yamashita T; Shimada Y
    Osteoporos Int; 2018 Dec; 29(12):2659-2665. PubMed ID: 30105400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.